International Clinical Trial: Efficacy and Safety of Compound Raceanisodamine Eye Drops in the Treatment of Asthenopia in Chinese Adolescents with Refractive Error: A Single-Center, Randomized, Open-Label, Positive Parallel-Controlled Study

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132768) titled 'Efficacy and Safety of Compound Raceanisodamine Eye Drops in the Treatment of Asthenopia in Chinese Adolescents with Refractive Error: A Single-Center, Randomized, Open-Label, Positive Parallel-Controlled Study' on Sept. 18.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Eye Hospital, Wenzhou Medical University

Condition: asthenopia

Intervention: Test group:Compound Racemic Scopolamine Eye Drops: 1 to 2 drops three times daily for 30 days

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-23

Target Sample Size: Test group:37;Control group:37; ...